[EN] CARBON MONOXIDE-RELEASING MOLECULES TRIGGERED BY PHYSIOLOGICAL STIMULI<br/>[FR] MOLÉCULES À LIBÉRATION DE MONOXYDE DE CARBONE DÉCLENCHÉE PAR DES STIMULI PHYSIOLOGIQUES
申请人:UNIV GEORGIA STATE RES FOUND
公开号:WO2019032879A1
公开(公告)日:2019-02-14
The present invention generally relates to carbon monoxide releasing compounds and compositions, and their use as carbon monoxide prodrugs.
本发明一般涉及一氧化碳释放化合物和组合物,以及它们作为一氧化碳前药的用途。
Captodative substituent effects XXI.
作者:S. Piettre、Z. Janousek、R. Merenyi、H.G. Viehe
DOI:10.1016/s0040-4020(01)96649-9
日期:1985.1
reacts more slowly, producing mainly the α-selenenyl adduct. Dehydrohalogenation of adducts provides a general and valuable method for the preparation of olefins carrying methyl or phenylselenenyl groups in α-position to electron-withdrawingsubstituents.
Several capto-dative olefins containing the phenylselenenyl group have been obtained via selenenyl halide addition to acrylic derivatives followed by halide elimination. Some of the olefins efficiently trap the radicals formed from azobisisobutyronitrile (AIBN) and methyl azobisisobutyrate (MAIB) to form intermediate bridged dehydrodimers, which spontaneously lose diphenyldiselenide to produce new
作者:Zhixiang Pan、Jun Zhang、Kaili Ji、Vayou Chittavong、Xingyue Ji、Binghe Wang
DOI:10.1021/acs.orglett.7b02775
日期:2018.1.5
CO prodrugs with triggered release mechanisms are highly desirable for targeted delivery. Herein described are organic CO prodrugs that are activated by ROS and thus can be used to selectively deliver CO to cells with elevated ROS levels. Such CO prodrugs can serve as powerful tools for targeted delivery to disease sites with elevated ROS levels and to explore the therapeutic applications of CO.